Skip to main content
William Lumry, MD, Allergy & Immunology, Dallas, TX, Medical City Dallas

WilliamRaymondLumryMD

Allergy & Immunology Dallas, TX

Asthma & Allergic Conditions, Pediatric Asthma & Allergic Conditions

Allergy & Allergy Specialists

Dr. Lumry is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lumry's full profile

Already have an account?

Education & Training

  • Scripps Clinic/Scripps Green Hospital
    Scripps Clinic/Scripps Green HospitalFellowship, Allergy and Immunology, 1982
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1977 - 1980
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 1977 - 1978
  • University of Texas Medical Branch School of Medicine
    University of Texas Medical Branch School of MedicineClass of 1977

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1977 - 2025
  • CA State Medical License
    CA State Medical License 1980 - 1984
  • American Board of Allergy and Immunology Allergy & Immunology
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology
  • Whos Who in Medicine and Healthcare Marquis Whos Who
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Lanadelumab Compared with Placebo on Prevention of Hereditary Angioedema Attacks  
    Jonathan A Bernstein, Lawrence B Schwartz, Andrew M Smith, H James Wedner, Daniel Soteres, Timothy Craig, Douglas T Johnston, Aleena Banerji, Paula J Busse, William R ..., JAMA
  • Population Pharmacokinetics of Subcutaneous C1‐Inhibitor for Prevention of Attacks in Patients with Hereditary Angioedema  
    Jonathan A Bernstein, Marc A Riedl, Bruce Zuraw, H Henry Li, Timothy Craig, William R Lumry, Clinical and experimental allergy

Press Mentions

  • Trio Health (Trio) and the Consortium of Independent Immunology Clinics (CIIC) Announce the Launch of the Trio-CIIC HAE Registry
    Trio Health (Trio) and the Consortium of Independent Immunology Clinics (CIIC) Announce the Launch of the Trio-CIIC HAE RegistryMay 12th, 2022
  • Takhzyro in Easier to Use, Prefilled Syringe Now Available in US
    Takhzyro in Easier to Use, Prefilled Syringe Now Available in USApril 21st, 2022
  • Shire's Investigational Subcutaneous C1 Esterase Inhibitor (C1 INH [Human]) Liquid for Injection (SHP616) Significantly Reduces HAE Monthly Attack Rate Versus Placebo in a Phase 3 Pivotal Trial
    Shire's Investigational Subcutaneous C1 Esterase Inhibitor (C1 INH [Human]) Liquid for Injection (SHP616) Significantly Reduces HAE Monthly Attack Rate Versus Placebo in a Phase 3 Pivotal TrialSeptember 11th, 2017
  • Join now to see all

Professional Memberships

Other Languages

  • Spanish

Hospital Affiliations